Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation.

[1]  T. Clarkson,et al.  Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation , 2007, Climacteric : the journal of the International Menopause Society.

[2]  M. Rönnback,et al.  Effect of physical activity and muscle morphology on endothelial function and arterial stiffness , 2006, Scandinavian journal of medicine & science in sports.

[3]  T. Clarkson.  Does tibolone exacerbate atherosclerosis? , 2006, European heart journal.

[4]  F. Sacks,et al.  Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee , 2006, Circulation.

[5]  B. Erdoğmuş,et al.  Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause , 2006, Climacteric : the journal of the International Menopause Society.

[6]  T. L. Dog.  Menopause: a review of botanical dietary supplements , 2005 .

[7]  J. Cockcroft.  Exploring vascular benefits of endothelium-derived nitric oxide. , 2005, American journal of hypertension.

[8]  J. Eden.  The need for tissue selective menopausal agents , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[9]  P. Kenemans,et al.  Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. , 2005, Maturitas.

[10]  G. Paolisso,et al.  Effects of soy isoflavones on endothelial function in healthy postmenopausal women , 2005, Menopause.

[11]  J. Lampe,et al.  The in vitro metabolism of estrogens by human fecal bacteria; a comparison of equol-producers and non-producers , 2005 .

[12]  K. Setchell,et al.  S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. , 2005, The American journal of clinical nutrition.

[13]  C. Castelo-Branco,et al.  Vascular reactivity and atheromatous plaques in post-menopausal women on tibolone treatment. Open prospective study with Doppler ultrasonography in internal carotid artery. , 2005, Maturitas.

[14]  J. Lampe,et al.  Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health , 2005, Experimental biology and medicine.

[15]  A. McTiernan,et al.  Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  D. Grobbee,et al.  The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study. , 2004, European heart journal.

[17]  A. Villablanca,et al.  Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. , 2003, The American journal of clinical nutrition.

[18]  H. Adlercreutz,et al.  A Randomized Placebo‐Controlled Crossover Trial With Phytoestrogens in Treatment of Menopause in Breast Cancer Patients , 2003, Obstetrics and gynecology.

[19]  M. Erenus,et al.  Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries. , 2003, Fertility and sterility.

[20]  G. Mahady,et al.  Botanical dietary supplement use in peri- and postmenopausal women , 2003, Menopause.

[21]  K. Setchell,et al.  The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. , 2002, The Journal of nutrition.

[22]  J. Dwyer,et al.  Isoflavone supplementation and endothelial function in menopausal women , 2002, Clinical endocrinology.

[23]  T. Clarkson.  Soy, soy phytoestrogens and cardiovascular disease. , 2002, The Journal of nutrition.

[24]  J. Cockcroft,et al.  Assessment of arterial stiffness in clinical practice. , 2002, QJM : monthly journal of the Association of Physicians.

[25]  David J. Webb,et al.  Pulse‐Wave Analysis: Clinical Evaluation of a Noninvasive, Widely Applicable Method for Assessing Endothelial Function , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[26]  L. Lind,et al.  Endothelium-dependent vasodilation is related to the fatty acid composition of serum lipids in healthy subjects. , 2001, Atherosclerosis.

[27]  J. Erdman.  AHA Science Advisory: Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA. , 2000, Circulation.

[28]  A. Duncan,et al.  Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  M. O'Rourke,et al.  Pulse wave analysis. , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[30]  D. Grobbee,et al.  Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. , 2005, The American journal of clinical nutrition.